GB9705340D0 - Compositions - Google Patents

Compositions

Info

Publication number
GB9705340D0
GB9705340D0 GBGB9705340.9A GB9705340A GB9705340D0 GB 9705340 D0 GB9705340 D0 GB 9705340D0 GB 9705340 A GB9705340 A GB 9705340A GB 9705340 D0 GB9705340 D0 GB 9705340D0
Authority
GB
United Kingdom
Prior art keywords
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9705340.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GE Healthcare AS
Original Assignee
Nycomed Imaging AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Imaging AS filed Critical Nycomed Imaging AS
Priority to GBGB9705340.9A priority Critical patent/GB9705340D0/en
Publication of GB9705340D0 publication Critical patent/GB9705340D0/en
Priority to PCT/GB1998/000778 priority patent/WO1998041239A1/en
Priority to AU64125/98A priority patent/AU6412598A/en
Priority to EP98909643A priority patent/EP0988055A1/en
Priority to JP54024498A priority patent/JP2001515503A/en
Priority to NO994335A priority patent/NO994335L/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
    • A61K49/222—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/225—Microparticles, microcapsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
GBGB9705340.9A 1997-03-14 1997-03-14 Compositions Pending GB9705340D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GBGB9705340.9A GB9705340D0 (en) 1997-03-14 1997-03-14 Compositions
PCT/GB1998/000778 WO1998041239A1 (en) 1997-03-14 1998-03-16 Compositions comprising flexible particles, non-ionic surfactant and non-ionic cloud-point modifier
AU64125/98A AU6412598A (en) 1997-03-14 1998-03-16 Compositions comprising flexible particles, non-ionic surfactant and non-ionic cloud-point modifier
EP98909643A EP0988055A1 (en) 1997-03-14 1998-03-16 Compositions comprising flexible particles, non-ionic surfactant and non-ionic cloud-point modifier
JP54024498A JP2001515503A (en) 1997-03-14 1998-03-16 Composition comprising soft particles, a nonionic surfactant and a nonionic cloud point modifier
NO994335A NO994335L (en) 1997-03-14 1999-09-07 Composition consisting of flexible particles, nonionic surfactant and nonionic breakpoint modifier

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9705340.9A GB9705340D0 (en) 1997-03-14 1997-03-14 Compositions

Publications (1)

Publication Number Publication Date
GB9705340D0 true GB9705340D0 (en) 1997-04-30

Family

ID=10809255

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9705340.9A Pending GB9705340D0 (en) 1997-03-14 1997-03-14 Compositions

Country Status (6)

Country Link
EP (1) EP0988055A1 (en)
JP (1) JP2001515503A (en)
AU (1) AU6412598A (en)
GB (1) GB9705340D0 (en)
NO (1) NO994335L (en)
WO (1) WO1998041239A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9822158D0 (en) * 1998-10-09 1998-12-02 Nycomed Imaging As Compositions
CN103550155A (en) * 2013-11-08 2014-02-05 江南大学 Method of restraining production of lysophosphatide in lecithin/non-ionic surfactant mixed micelles
TWI820051B (en) * 2017-11-01 2023-11-01 日商武田藥品工業股份有限公司 Pharmaceutical compositions, methods for stabilizing pharmaceutical compositions, and methods for evaluating the storage stability of pharmaceutical compositions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6078916A (en) * 1983-10-03 1985-05-04 Tanpei Seiyaku Kk Preparation of stable suspension for internal use
JPS6087222A (en) * 1983-10-19 1985-05-16 Shionogi & Co Ltd Imidazole-type antimycotic emulsion for external use
SE470477B (en) * 1992-10-05 1994-05-24 Procell Bioteknik Ab Ointment containing fibronectin for the treatment of wounds
US5346702A (en) * 1992-12-04 1994-09-13 Sterling Winthrop Inc. Use of non-ionic cloud point modifiers to minimize nanoparticle aggregation during sterilization
US5352459A (en) * 1992-12-16 1994-10-04 Sterling Winthrop Inc. Use of purified surface modifiers to prevent particle aggregation during sterilization
US5326552A (en) * 1992-12-17 1994-07-05 Sterling Winthrop Inc. Formulations for nanoparticulate x-ray blood pool contrast agents using high molecular weight nonionic surfactants

Also Published As

Publication number Publication date
JP2001515503A (en) 2001-09-18
EP0988055A1 (en) 2000-03-29
NO994335L (en) 1999-11-05
AU6412598A (en) 1998-10-12
NO994335D0 (en) 1999-09-07
WO1998041239A1 (en) 1998-09-24

Similar Documents

Publication Publication Date Title
HUP9903759A3 (en) Abtimicrobial compositions
GB9726814D0 (en) Compositions
GB9702238D0 (en) Compositions
GB9704524D0 (en) Composition
GB9715203D0 (en) Composition
IL130856A0 (en) Peroxetine compositions
GB9713620D0 (en) Composition
GB9726543D0 (en) Novel compositions
GB9711683D0 (en) Composition
GB9715489D0 (en) Composition
GB9714010D0 (en) Composition
EP0958806A4 (en) Haircoloring composition
GB9724838D0 (en) Compositions
GB9701031D0 (en) Composition
GB9714359D0 (en) Composition
GB9705340D0 (en) Compositions
GB9703109D0 (en) Compositions
GB9705813D0 (en) Novel compositions
GB9712981D0 (en) Compositions
GB2336368B (en) Compositions
GB9705110D0 (en) Composition
GB9724670D0 (en) Compositions
GB9717523D0 (en) Compositions
GB9713213D0 (en) Compositions
GB9709128D0 (en) Compositions